TD Asset Management »

Lenz Therapeutics shares owned by TD Asset Management

Quarter-by-quarter ownership of Lenz Therapeutics (LENZ) shares owned by TD Asset Management from 13F filings

Historical chart of TD Asset Management investment in Lenz Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Lenz Therapeutics held by TD Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lenz Therapeutics by TD Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.5M 31k 46.58
2025-03-31 $895k 35k 25.71
2024-12-31 $3.0M 103k 28.87
2024-09-30 $681k 28k 24.04